Increased LAMP2 expression is observed in poorly differentiated human gastric adenocarcinoma, hepatocellular carcinoma, salivary adenoid cystic carcinoma, and invasive prostate carcinoma, as well as in patients with esophageal squamous cell carcinoma [42,43,44,45,46]. This evidence concerns the gene LAMP2 and hepatocellular carcinoma.